Mortality and cause of death in multiple sclerosis: Findings from a prospective population-based cohort in bizkaia, basque country, Spain

Neuroepidemiology

Volumn 42, Issue 4, 2014, Pages 219-225

  Rodríguez Antigüedad Zarranz, Alfredo ^a   Mendibe Bilbao, Mar ^b   Llarena González, Cristina ^a   Audicana, Covadonga ^c  

^a HOSPITAL DE BASURTO   (Spain)

^b HOSPITAL DE CRUCES   (Spain)

^c Departamento de Salud 2   (Spain)

Author keywords

Cause of death; Epidemiology; Mortality; Multiple sclerosis; Survival

Indexed keywords

DISEASE MODIFYING ANTIMULTIPLE SCLEROSIS DRUG; MISCELLANEOUS DRUGS AND AGENTS; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CAUSE OF DEATH; COHORT ANALYSIS; CONSULTATION; DEATH CERTIFICATE; DISEASE COURSE; DISEASE DURATION; EXPANDED DISABILITY STATUS SCALE; FATALITY; FEMALE; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MULTIPLE SCLEROSIS; POPULATION RESEARCH; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; SEPSIS; SPAIN; STANDARDIZED MORTALITY RATIO; SURVIVAL; SURVIVOR; TIME OF DEATH; CARDIOPULMONARY INSUFFICIENCY; CEREBROVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DEVICE INFECTION; FOLLOW UP; GASTROINTESTINAL DISEASE; LUNG EMBOLISM; MORTALITY; ONSET AGE; POPULATION BASED CASE CONTROL STUDY; PROSPECTIVE STUDY; PUMP; REGISTER; RELAPSE; REMISSION; SEX DIFFERENCE; SEX RATIO; SUICIDE; SURVIVAL TIME; EPIDEMIOLOGY;

ADULT; AGE OF ONSET; CAUSE OF DEATH; COHORT STUDIES; FEMALE; HUMANS; MALE; MULTIPLE SCLEROSIS; PROSPECTIVE STUDIES; SPAIN; SURVIVAL ANALYSIS;

EID: 84899779041     PISSN: 02515350     EISSN: 14230208     Source Type: Journal    
DOI: 10.1159/000359971     Document Type: Article

References (16)

1. Rosati G: The prevalence of multiple sclerosis in the world: an update. Neurol Sci 2001; 22: 117-139.
2. Loma I, Heyman R: Multiple sclerosis: pathogenesis and treatment. Curr Neuropharmacol 2011; 9: 409-416.
3. Weinshenker BG, Bass B, Rice GP, et al: The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. Brain 1989; 112: 133-146.
4. Grytten Torkildsen N, Lie SA, Aarseth JH, Nyland H, Myhr KM: Survival and cause of death in multiple sclerosis from a 50-year follow-up in Western Norway. Mult Scler 2008; 14: 1191-1198.
5. Brønnum-Hansen H, Koch-Henriksen N, Stenager E: Trends in survival and cause of death in Danish patients with multiple sclerosis. Brain 2004; 127: 844-850.
6. Hirst C, Swingler R, Compston DAS, Ben-Shlomo Y, Robertson NP: Survival and cause of death in multiple sclerosis: a prospective population-based study. J Neurol Neurosurg Psychiatry 2008; 79: 1016-1021.
7. Sumelahti MJ, Hakama M, Elovaara I, Pukkala E: Causes of death among patients with multiple sclerosis. Mult Scler 2010; 16: 1437-1442.
8. Wallin MT, Page WF, Kurtze JF: Epidemiology of multiple sclerosis in US veterans. VIII. Long-term survival after multiple sclerosis. Brain 2000; 123: 1677-1687.
9. Kingwell E, van der Kop M, Zhao Y, Shirani A, Zhu F, Oger J, Tremlett H: Relative mortality and survival in multiple sclerosis: findings from British Columbia, Canada. J Neurol Neurosurg Psychiatry 2012; 83: 61-66.
10. Leray E, Morrissey SP, Yaouanq J, Coustans M, Le Page E, Chaperon J, Edan G: Long-term survival of patients with multiple sclerosis in West France. Mult Scler 2007; 13: 865-874.
11. Confavreux C, Vukusic S: Natural history of multiple sclerosis: a unifying concept. Brain 2006; 129: 606-616.
12. Degenhardt A, Ramagopalan SV, Scalfari A, Ebers GC: Clinical prognostic factors in multiple sclerosis: a natural history review. Nat Rev Neurol 2009; 5: 672-682.
13. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW: New diagnostic criteria for multiple sclerosis. Guidelines for research protocols. Ann Neurol 1983; 13: 227-231.
14. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS: Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2010; 50: 121-127.
15. Hirst C, Ingram G, Swingler R, Compston DAS, Pickerrsgill T, Robertson NP: Change in disability in patients with multiple sclerosis: a 20-year prospective population-based analysis. J Neurol Neurosurg Psychiatry 2008; 79: 1137-1143.
16. Goodin DS, Reder AT, Ebers GC, et al: Survival in MS: A randomized cohort study 21 years after the start of pivotal IFN-1b trial. Neurology 2012; 78: 1315-1322.